AMCADOP-CV 325 – Cefpodoxime Proxetil 200 mg + Clavulanic Acid 125 mg Tablets

AMCADOP-CV 325 is a combination antibiotic tablet containing Cefpodoxime Proxetil equivalent to Cefpodoxime 200 mg and Clavulanic Acid 125 mg per film-coated tablet. It combines a third-generation cephalosporin antibiotic with a beta-lactamase inhibitor and is prescribed for the treatment of certain susceptible bacterial infections.

AMCADOP-CV 325 Composition

Each film-coated tablet contains:

• Cefpodoxime Proxetil IP equivalent to Cefpodoxime – 200 mg
• Potassium Clavulanate Diluted IP equivalent to Clavulanic Acid – 125 mg
• Excipients – q.s.

Brand: AMCADOP-CV 325
Generic: Cefpodoxime Proxetil + Clavulanic Acid
Strength: 200 mg + 125 mg
Dosage Form: Film-Coated Tablet
Therapeutic Category: Antibacterial & Antibiotics
Pack Size: 10 × 1 × 10 Tablets
Route: Oral

Therapeutic Uses of AMCADOP-CV 325

AMCADOP-CV 325 belongs to the Antibacterial & Antibiotics therapeutic category.

It may be prescribed for susceptible bacterial infections, including:

• Respiratory tract infections
• Acute bacterial bronchitis
• Community-acquired pneumonia
• Ear infections such as acute otitis media
• Skin and soft tissue infections
• Urinary tract infections
• Other susceptible bacterial infections as determined by a qualified healthcare professional

AMCADOP-CV 325 should be used only for appropriate bacterial infections and is not effective against viral infections such as common cold or influenza.

Benefits of AMCADOP-CV 325

• Contains Cefpodoxime 200 mg + Clavulanic Acid 125 mg
• Combines a cephalosporin antibiotic with a beta-lactamase inhibitor
• Convenient film-coated tablet formulation
• Provides antibacterial activity against susceptible bacteria
• Suitable for oral administration when prescribed by a healthcare professional

How Does AMCADOP-CV 325 Work?

AMCADOP-CV 325 contains Cefpodoxime and Clavulanic Acid.

Cefpodoxime is a third-generation cephalosporin antibiotic that interferes with bacterial cell wall synthesis, helping inhibit the growth of susceptible bacteria.

Clavulanic Acid is a beta-lactamase inhibitor. It helps inhibit certain beta-lactamase enzymes produced by bacteria, which can otherwise reduce the activity of some beta-lactam antibiotics. This combination can provide broader antibacterial coverage against susceptible organisms.

AMCADOP-CV 325 Dosage and Administration

The appropriate dose and duration of AMCADOP-CV 325 depend on the type and severity of infection, patient’s age, kidney function and other clinical factors.

Take the medicine exactly as prescribed by the doctor.

The tablet should be taken according to the directions provided by the healthcare professional. Do not alter the prescribed dose or discontinue antibiotic treatment without medical advice.

Possible Side Effects of AMCADOP-CV 325

Some patients may experience:

• Diarrhea
• Nausea
• Vomiting
• Abdominal discomfort
• Indigestion
• Headache
• Skin rash

Seek immediate medical attention if severe allergic reactions, difficulty breathing, facial or throat swelling, severe skin reactions or persistent severe diarrhea occurs.

Precautions for AMCADOP-CV 325

Before taking AMCADOP-CV 325, inform your doctor if you:

• Have an allergy to Cefpodoxime, cephalosporins or other beta-lactam antibiotics
• Have previously experienced an allergic reaction to penicillin
• Have kidney problems
• Have a history of antibiotic-associated diarrhea
• Are taking other medicines or supplements
• Have any significant underlying medical condition

AMCADOP-CV 325 should be used under appropriate medical supervision.

AMCADOP-CV 325 and Antibiotic Resistance

Antibiotics should be used responsibly. AMCADOP-CV 325 should not be used for viral infections such as common cold or influenza.

Follow the prescribed dosage and treatment duration. Unnecessary or inappropriate use of antibiotics may contribute to antibiotic resistance.

Frequently Asked Questions About AMCADOP-CV 325

What is AMCADOP-CV 325?

AMCADOP-CV 325 is a combination antibiotic tablet containing Cefpodoxime 200 mg and Clavulanic Acid 125 mg.

What is AMCADOP-CV 325 used for?

It may be prescribed for susceptible bacterial infections such as respiratory tract infections, pneumonia, ear infections, skin and soft tissue infections and urinary tract infections.

What is the composition of AMCADOP-CV 325?

Each film-coated tablet contains Cefpodoxime equivalent to 200 mg and Clavulanic Acid 125 mg.

What is the strength of AMCADOP-CV 325?

Each tablet contains Cefpodoxime 200 mg + Clavulanic Acid 125 mg.

Is AMCADOP-CV 325 an antibiotic?

Yes. AMCADOP-CV 325 is a combination antibacterial antibiotic containing Cefpodoxime and Clavulanic Acid.

Can AMCADOP-CV 325 be used for cold and flu?

No. It does not treat viral infections such as common cold or influenza. It should be used only for an appropriate bacterial infection as prescribed by a doctor.